| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |